JNJ vs INCY
By Alex · Tickerpine
Johnson & Johnson vs Incyte Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | INCY |
|---|---|---|
| Price | $263.81 | $115.71 |
| Market cap | $635.07B | $23.45B |
| P/E ratio | 40.0 | 14.7 |
| ROE | 20.02% | 30.67% |
| Profit margin | 16.20% | 27.71% |
| Revenue growth | 5.90% | 37.70% |
| Dividend yield | 2.03% | 0.00% |
| Beta | 0.21 | 0.74 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs INCY in plain English
- JNJ is the bigger company — about 27.1× the market cap of INCY.
- INCY is cheaper on earnings (P/E 14.7 vs 40.0).
- INCY earns a higher return on equity (31% vs 20%).
- INCY is growing revenue faster (38% vs 6%).
- JNJ pays a dividend (2.03%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
INCY return calculator
See what $1,000 in Incyte Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.